M.G. DeGroote Institute for Infectious Disease Research, McMaster University, 1200 Main St W, Hamilton, ON, Canada.
Chem Commun (Camb). 2011 Apr 14;47(14):4055-61. doi: 10.1039/c0cc05111j. Epub 2011 Feb 1.
Over the past decade, resistance to antibiotics has emerged as a crisis of global proportion. Microbes resistant to many and even all clinically approved antibiotics are increasingly common and easily spread across continents. At the same time there are fewer new antibiotic drugs coming to market. We are reaching a point where we are no longer able to confidently treat a growing number of bacterial infections. The molecular mechanisms of drug resistance provide the essential knowledge on new drug development and clinical use. These mechanisms include enzyme catalyzed antibiotic modifications, bypass of antibiotic targets and active efflux of drugs from the cell. Understanding the chemical rationale and underpinnings of resistance is an essential component of our response to this clinical challenge.
在过去的十年中,抗生素耐药性已经成为全球性的危机。对许多甚至所有临床批准的抗生素都具有耐药性的微生物越来越常见,并且容易在各大洲传播。与此同时,市场上推出的新抗生素药物越来越少。我们正处于一个无法自信地治疗越来越多细菌感染的地步。耐药性的分子机制为新药开发和临床应用提供了必要的知识。这些机制包括酶催化的抗生素修饰、抗生素靶标的绕过以及药物从细胞中的主动外排。了解耐药性的化学原理和基础是我们应对这一临床挑战的重要组成部分。